Literature DB >> 3709639

Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.

E Malacco, F Mailland, E Bosisio, R Meroni, R Dagani, E Renesto, M Bevilacqua.   

Abstract

The haemodynamic effect of indenolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity (ISA) in animals, has been evaluated in a double-blind cross-over randomized trial after acute (3 days) and long-term treatment (28 days), in 12 hypertensive patients in comparison with that of propranolol. Patients were evaluated at rest and during isometric exercise (hand grip). The overall acute effect of both beta-adrenoceptor blocking drugs was to decrease mean blood pressure, heart rate and cardiac output, while total peripheral resistance increased. In the long-term studies the haemodynamic effect of propranolol was still characterized by cardiodepression and unchanged peripheral resistance. Patients on the long-term treatment with indenolol showed normal cardiac output and reduced total peripheral resistance. The data are compatible with a relatively strong ISA of indenolol, which would be responsible for the haemodynamic pattern observed during chronic treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709639     DOI: 10.1007/bf00614294

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

Review 1.  Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  J Cardiovasc Pharmacol       Date:  1983       Impact factor: 3.105

2.  -adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2).

Authors:  T Tanenaka; S Tachikawa
Journal:  Arzneimittelforschung       Date:  1972-11

3.  Interaction between cardiovascular responses to sustained handgrip and Valsalva manoeuvre.

Authors:  D J Ewing; F Kerr; R Leggett; A Murray
Journal:  Br Heart J       Date:  1976-05

4.  Dose-response studies of indenolol, a beta adrenoceptor blocker.

Authors:  F E Okupa; T K Daneshmend; E Shrosbree; C J Roberts
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

5.  Validation of the CO2 rebreathing method for measuring cardiac output in patients with hypertension or heart failure.

Authors:  J A Franciosa; D O Ragan; S J Rubenstone
Journal:  J Lab Clin Med       Date:  1976-10

6.  Ventilatory and pressor response to isometric exercise in normal subjects.

Authors:  E Bosisio; A Arosio; V Mandelli; M Sergi
Journal:  Respiration       Date:  1980       Impact factor: 3.580

7.  Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.

Authors:  S Tachikawa; T Takenaka
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-03

8.  Acute effect of indenolol on systemic arterial pressure and heart rate in the rat.

Authors:  G Zuccari; A Falcone; C Turba
Journal:  Pharmacol Res Commun       Date:  1986-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.